Evidence map›Paper›PMID 36999196›Full record

ArticleTechnology in cancer research & treatment

GOLM1 Promotes Epithelial-Mesenchymal Transition by Activating TGFβ1/Smad2 Signaling in Prostate Cancer.

Xuke Qin, Lin Liu, Yanze Li, Hongbo Luo, Hui Chen, Xiaodong Weng

Open access · goldAbstract read
In one paragraph

Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Identification of a 24-gene panel and a novel marker ofComputational and structural biotechnology journal · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Xuke Qin117921Renmin Hospital of Wuhan University, Wuhan, Hubei, China.ORCID 0000-0001-9273-3081
Lin LiuRenmin Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
Yanze Li117921Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Hongbo Luo117921Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Hui Chen117921Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Xiaodong Weng117921Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Wuhan University · CNHubei University of Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Prostatic NeoplasmsTransforming Growth Factor beta1Cell Line, TumorCell MovementEpithelial-Mesenchymal TransitionHumansMaleMembrane ProteinsSignal TransductionSmad2 ProteinGOLM1 protein, humanMembrane ProteinsSmad2 ProteinSMAD2 protein, humanTransforming Growth Factor beta1epithelial-mesenchymal transitionGOLM1prostate cancerTGF-β1

Identifiers

PMID36999196
PMCPMC10071148
OpenAlexW4362032334

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.